HF
CRDL

HRT Financial’s Cardiol Therapeutics CRDL Stock Holding History

HRT Financial’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50K Buy
+47,179
New +$59.7K ﹤0.01% 3776
2025
Q4 		– Sell
-49,293
Closed -$52K – 3291
2025
Q3 		$52K Buy
+49,293
New +$59.8K ﹤0.01% 2600
2023
Q4 		– Sell
-12,345
Closed -$11K – 2417
2023
Q3 		$11K Buy
+12,345
New +$11.8K ﹤0.01% 2114

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $3.2B AUM 23.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HRT Financial's CRDL Position: Q2 2026 in Review

HRT Financial opened a new position in Cardiol Therapeutics (CRDL) in Q2 2026: 47,179 shares worth $50K. The stake represents ﹤0.01% of the portfolio and ranks #3776 among its holdings. This is a return to the name: HRT Financial previously reported a position in CRDL as recently as Q3 2025.

HRT Financial first reported a position in CRDL in Q3 2023 and has held it in 3 quarters since. The position peaked at $52K in Q3 2025. 52 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

  • HRT Financial held 47,179 shares of Cardiol Therapeutics worth $50K as of Q2 2026.
  • Cardiol Therapeutics was a new HRT Financial position in Q2 2026.
  • Cardiol Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3776 holding.
  • HRT Financial first reported a position in Cardiol Therapeutics in Q3 2023 and has held it in 3 quarters since.
  • HRT Financial's Cardiol Therapeutics position peaked at $52K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.